FDA approves belzutifan for VHL kidney cancer
The FDA has approved a new drug called belzutifan for [...]
FDA approves pembrolizumab plus lenvatinib combination for advanced kidney cancer
The US Food and Drug Administration (FDA) has approved the [...]
FDA grants priority review for HIF-2α inhibitor belzutifan (MK-6482)
The US Food and Drug Administration (FDA) has granted priority [...]
Cabozantinib plus nivolumab granted FDA approval for first-line treatment of advanced kidney cancer
The Food and Drug Administration (FDA) in the United States has [...]
Ilixadencel granted Regenerative Medicine Advanced Therapy by FDA for metastatic kidney cancer
The US Food and Drug Administration (FDA) has designated ilixadencel [...]
Generic everolimus approved by the FDA
The US Food and Drug Administration (FDA) has approved generic [...]
Avelumab plus axitinib granted FDA approval for advanced kidney cancer
The Food and Drug Administration (FDA) in the United States [...]
Pembrolizumab plus axitinib granted FDA approval for advanced kidney cancer
The Food and Drug Administration (FDA) in the United States [...]
Synthetic or plant-based cannabis for symptom relief in patients with cancer
This article discusses the evidence available for synthetic and plant-based [...]
FDA grants Fast Track designation to glutaminase inhibitor combination for metastatic kidney cancer
The glutaminase inhibitor, CB-839 has been granted Fast Track designation [...]
